{"id":104422,"date":"2021-01-12T16:14:43","date_gmt":"2021-01-12T16:14:43","guid":{"rendered":"https:\/\/fin2me.com\/?p=104422"},"modified":"2021-01-12T16:14:43","modified_gmt":"2021-01-12T16:14:43","slug":"pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/","title":{"rendered":"Pfizer forecasts 2021 earnings of $3 to $3.10 per share"},"content":{"rendered":"<figcaption>FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS\/Dado Ruvic\/Illustration<\/figcaption><p>(Reuters) &#8211; Pfizer Inc expects 2021 earnings of between $3 and $3.10 per share, Chief Executive Officer Albert Bourla said at a J.P. Morgan healthcare conference on Tuesday.<\/p>\n<p>Wall Street analysts on average expect Pfizer to earn $3.07 per share, according to IBES data from Refinitiv.<\/p>\n<p>Source: <a href=\"https:\/\/www.reuters.com\/article\/us-pfizer-outlook\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share-idUSKBN29H248\" target=\"_blank\" rel=\"noopener noreferrer\">Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS\/Dado Ruvic\/Illustration(Reuters) &#8211; [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":104421,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me\" \/>\n<meta property=\"og:description\" content=\"FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS\/Dado Ruvic\/Illustration(Reuters) &#8211; [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-12T16:14:43+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/01\/cnewsfotor27-2.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/\",\"url\":\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/\",\"name\":\"Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-01-12T16:14:43+00:00\",\"dateModified\":\"2021-01-12T16:14:43+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Business\",\"item\":\"https:\/\/fin2me.com\/category\/business\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pfizer forecasts 2021 earnings of $3 to $3.10 per share\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me","og_description":"FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS\/Dado Ruvic\/Illustration(Reuters) &#8211; [...]","og_url":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/","og_site_name":"Fin2me","article_published_time":"2021-01-12T16:14:43+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/01\/cnewsfotor27-2.jpg","twitter_misc":{"Written by":"Mark"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/","url":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/","name":"Pfizer forecasts 2021 earnings of $3 to $3.10 per share - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-01-12T16:14:43+00:00","dateModified":"2021-01-12T16:14:43+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/business\/pfizer-forecasts-2021-earnings-of-3-to-3-10-per-share\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Business","item":"https:\/\/fin2me.com\/category\/business\/"},{"@type":"ListItem","position":3,"name":"Pfizer forecasts 2021 earnings of $3 to $3.10 per share"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/104422"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=104422"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/104422\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/104421"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=104422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=104422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=104422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}